Skip to main content
. 2023 Jun 22;14:1181452. doi: 10.3389/fendo.2023.1181452

Table 2.

Comparison of bioclinical characteristics in subjects with low versus high myocardial triglyceride content.

Low MTGC ≤ 0.31%
(n=84)
High MTGC >1.09%
(n=84)
p value
Clinical data
Sex ratio: women (n, %) 46 (54.8%) 58 (69.1%) 0.08
Age (years) 22 [21;29.8] 51 [34;58.8] <0.0001
BMI (kg/m²) 21.8 [19.7;24.7] 35.3 [28.9;41.5] <0.0001
WC (cm):
-women
-men

70.5 [64.5;81.5]
78.3 [74.8;85.6]

111 [99.5;125]
110 [91.3;119.8]

<0.0001
<0.0001
T2D (n, %) 8 (9.5%) 52 (61.9%) <0.0001
Obesity (n, %) 11 (13.1%) 62 (73.8%) <0.0001
Dyslipidemia (n, %) 5 (5.9%) 39 (46.4%) <0.0001
Arterial hypertension (n, %) 5 (5.9%) 37 (44.1%) <0.0001
Biological data
Total cholesterol (mmol/L) 4.3 [3.8;4.7] 4.4 [3.5;5.1] 0.79
Triglycerides (mmol/L) 0.8 [0.6;1.2] 1.4 [1.0;2.1] <0.0001
HDL (mmol/L) 1.4 [1.1;1.6] 1.1 [1.0;1.4] <0.0001
LDL (mmol/L) 2.4 ( ± 0.7) 2.5 ( ± 0.8) 0.909
Fasting plasma glucose (mmol/L) 4.7 [4.7;5.1] 6.7 [5.0;8.9] <0.0001
Fasting plasma insulinemia (mUI/L) 6.9 [5.0;9.9] 14.1 [8.7;21.7] <0.0001
HOMA-IR 1.4 [1.0;8.6] 3.7 [1.7;6.6] <0.0001

Data expressed as mean ± standard deviation (SD) or as median [25th percentile;75th percentile].

BMI, body mass index; HOMA-IR, homeostatic model assessment of insulin resistance; MTGC, myocardial triglyceride content; HDL, high-density lipoprotein; LDL, low-density lipoprotein; T2D, type 2 diabetes; WC, waist circumference.